Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Evolutionary Analysis Predicts Sensitive Positions of MMP20 and Validates Newly- and Previously-Identified MMP20 Mutations Causing Amelogenesis Imperfecta.
|
28659819 |
2017 |
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Analyses of MMP20 Missense Mutations in Two Families with Hypomaturation Amelogenesis Imperfecta.
|
28473773 |
2017 |
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Evolutionary Analysis Predicts Sensitive Positions of MMP20 and Validates Newly- and Previously-Identified MMP20 Mutations Causing Amelogenesis Imperfecta.
|
28659819 |
2017 |
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
Homozygous and compound heterozygous MMP20 mutations in amelogenesis imperfecta.
|
23625376 |
2013 |
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
Biomarker
|
disease |
MGD |
Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype.
|
12393861 |
2002 |
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Amelogenesis Imperfecta, Hypomaturation Type, Iia2
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Evolutionary Analysis Predicts Sensitive Positions of MMP20 and Validates Newly- and Previously-Identified <i>MMP20</i> Mutations Causing Amelogenesis Imperfecta.
|
28659819 |
2017 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
BEFREE |
Therefore, we attributed the AI primarily to the reduction of MMP20 and KLK4.
|
27146352 |
2016 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
BEFREE |
Novel MMP20 and KLK4 Mutations in Amelogenesis Imperfecta.
|
26124219 |
2015 |
Amelogenesis Imperfecta
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We suggest that the pathogenesis of this form of AI may be due to ineffective ligand binding of ITGB6 resulting in either compromised cell-matrix interaction or compromised ITGB6 activation of transforming growth factor-β (TGF-β) impacting indirectly on ameloblast-ameloblast interactions and proteolytic processing of extracellular matrix proteins via MMP20.
|
24319098 |
2014 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Homozygous and compound heterozygous MMP20 mutations in amelogenesis imperfecta.
|
23625376 |
2013 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Amelogenesis imperfecta (AI) is an inherited disorder that is associated with mutations in five genes (AMEL; ENAM; MMP20; KLK4 and FAM83H) with a wide range of clinical presentations (phenotypes).
|
22538897 |
2012 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We have since expanded the number of AI kindreds to 39, and performed mutation analyses covering the coding exons and adjoining intron sequences for the six proven AI candidate genes [amelogenin (AMELX), enamelin (ENAM), family with sequence similarity 83, member H (FAM83H), WD repeat containing domain 72 (WDR72), enamelysin (MMP20), and kallikrein-related peptidase 4 (KLK4)] and for ameloblastin (AMBN) (a suspected candidate gene).
|
22243262 |
2011 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
MMP20 hemopexin domain mutation in amelogenesis imperfecta.
|
19966041 |
2010 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
BEFREE |
The proven candidate genes for amelogenesis imperfecta (AI) are AMELX, ENAM, MMP20, KLK4, FAM83H, and WDR72.
|
20938048 |
2010 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
We have identified an ARAI-causing point mutation (c.102G>A, g.102G>A, and p.W34X) in exon 1 of MMP20 in a proband with autosomal-recessive hypoplastic-hypomaturation amelogenesis imperfecta.
|
18096894 |
2008 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Our study supports a model in which the P41T mutation reduces the interactions between amelogenin and MMP20, leading to decreased degradation of amelogenin by MMP20, and resulting in AI.
|
18434575 |
2008 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
BEFREE |
Genes expressed by odontoblasts (COL1A1, COL1A2, and DSPP), and ameloblasts (AMELX, ENAM, MMP20, and KLK4) during the crown formation stage, are associated with dentinogenesis imperfecta, dentin dysplasia, and amelogenesis imperfecta.
|
17552940 |
2007 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
LHGDN |
MMP-20 mutation in autosomal recessive pigmented hypomaturation amelogenesis imperfecta.
|
15744043 |
2005 |
Amelogenesis Imperfecta
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
To determine the frequency of mutations in these genes, we analyzed 15 Turkish probands with autosomal-recessive hypomaturation AI for MMP20 and KLK4 gene mutations.No KLK4 mutations were found.
|
16246936 |
2005 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
BEFREE |
This study suggests that the reduced rate of TRAP formation by a single amino acid substitution alters enamel matrix hydrolysis by MMP-20, which may result in amelogenesis imperfecta.
|
12648554 |
2003 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
MGD |
Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype.
|
12393861 |
2002 |
Amelogenesis Imperfecta
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Amelogenesis Imperfecta hypomaturation type
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
MMP-20 mutation in autosomal recessive pigmented hypomaturation amelogenesis imperfecta.
|
15744043 |
2005 |